Gianluca Civenni

Research associate
Therapeutics
Oncology Institute of Southern Switzerland
Switzerland

Academician Oncology
Biography

In 2011, Gianluca moved to the Institute of Oncology Research, where he is leading a program aimed to design RNAi-based therapy to target specifically cancer stem cells in prostate malignancies. In addition, he is responsible for writing the guidelines for in vivo imaging and flow cytometry. In his free time he enjoys cooking and manages his B&B Casa Civenni at the lakeside of the Lago Maggiore.

Research Intrest

Cell Biology, Molecular Biology, In Vivo, Cancer Research, Biochemistry,Cell Culture,Life Sciences, In Vitro, Confocal Microscopy, Cell Cancer, Fluorescence Microscopy, Animal Models, Microscopy, Immunohistochemistry, Western Blotting , Genetics, Biotechnology, Molecular Cloning, Protein Expression, Stem Cells, Genomics, Scientific Writing , Lifesciences , Flow Cytometry , Neuroscience , Cell Signaling, Bioinformatics, FACS , Protein Chemistry, Tissue Culture , qPCR, Biomarkers.

List of Publications
Civenni G, Malek A, Albino D, Garcia-Escudero R, Napoli S, Di Marco S, Pinton S, Sarti M, Carbone GM, Catapano CV. RNAi-mediated silencing of Myc transcription inhibits stem-like cell maintenance and tumorigenicity in prostate cancer. Cancer research. 2013 Nov 15;73(22):6816-27.
Civenni G, Test ST, Brodbeck U, Bütikofer P. In vitro incorporation of GPI-anchored proteins into human erythrocytes and their fate in the membrane. Blood. 1998 Mar 1;91(5):1784-92.
Civenni G, Holbro T, Hynes NE. Wnt1 and Wnt5a induce cyclin D1 expression through ErbB1 transactivation in HC11 mammary epithelial cells. EMBO reports. 2003 Feb 1;4(2):166-71.
Civenni G, Walter A, Kobert N, Mihic-Probst D, Zipser M, Belloni B, Seifert B, Moch H, Dummer R, van den Broek M, Sommer L. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer research. 2011 Apr 15;71(8):3098-109.